Q4 2025 earnings call recap: revenue surge, 2026 guidance, Mounjaro/Zepbound momentum, pricing risks, and Medicare access—read now.
Unfortunately, when it rains, it pours, and there could be more bad news heading UnitedHealth's way regarding Medicare. The ...
This is not hard to figure out. When there’s this much money, it’s going into somebody’s pockets,” said New York State Senate ...
Trump’s Centers for Medicare and Medicaid Services proposed two new rules that, if allowed to go into effect in their current state, would severely restrict young trans people’s access to life-saving ...
The agency quietly released a memo updating MA plans on how it’s approaching risk adjustment data validation audits after a ...
Medicare beneficiaries whose physicians participate in accountable care organizations (ACOs), particularly those taking on financial risk for cost and quality, receive substantially more primary and ...
The funding package ends a partial government shutdown and enacts several healthcare policies, including preserving ...
The pilot, launched in January 2026 in 6 states, could reduce wasteful spending, but increases provider paperwork and risks ...
Objective: To address concerns about payment adequacy in Medicare Advantage (MA) plans, a 2017 federal policy change increased risk scores and associated capitated payments for community-dwelling ...
The government proposed boosting payments to Medicare Advantage plans by 0.09% in 2027, below what they and their investors expected. What would it mean for enrollees?
President Trump signed into law a two-year extension of telehealth services for older adults covered by the Medicare health ...
Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the second quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results